CTC Bio Inc. | Mutual Funds
Mutual Funds that own CTC Bio Inc.
DFA Emerging Markets Small Cap Series
82,400
0.47%
0
0.01%
01/31/2018
DFA Emerging Markets Core Equity Portfolio
52,973
0.3%
5,966
0%
04/30/2018
SPDR S&P International Small Cap ETF
6,596
0.04%
0
0.01%
09/06/2018
DFA TA World (ex-US) Core Equity Portfolio
5,077
0.03%
0
0%
04/30/2018
Dimensional Funds ICVC - Emerging Markets Core Equity Fund
3,160
0.02%
1,763
0%
12/31/2017
John Hancock II - Emerging Markets Fund
2,903
0.02%
0
0%
04/30/2018
DFA Emerging Markets Social Core Equity Portfolio
1,736
0.01%
0
0%
04/30/2018
570
0%
-1,892
0.22%
01/31/2017
DFA World (ex-US) Core Equity Portfolio
0
0%
-2,647
0%
04/30/2018
| Address |
6th Floor, Sambo Building
Seoul SL 05724
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.ctcbio.com |
| Updated |
09/14/2018 |
| CTC Bio, Inc. engages in the manufacture of pharmaceuticals, functional food and animal health products. It operates through following divisions: Animal Health and Human Medicine. The Animal Health division produces antibiotic, enzyme, probiotic products and bird flu-related diagnostic kits and disinfectants. |
